Search Results

Filter
  • 1-10 of  149,204 results for ""Killer Cells, Natural""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.

  • Authors : Gunasena M; Department of Microbial Infection and Immunity, College of Medicine (M.G., M.A., Y.W., W.M., K.W., S.-L.L., N.P.M.L.), The Ohio State University, Columbus.; Department of Veterinary Bioscience, College of Veterinary Medicine (M.G., S.-L.L., N.P.M.L.), The Ohio State University, Columbus.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/complications

  • Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2024 Oct; Vol. 44 (10), pp. e243-e261. Date of Electronic Publication: 2024 Jul 11.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases.

  • Authors : Fife C; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.; Cancer Research UK National Biomarker Centre, The University of Manchester, Manchester, UK.

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/metabolism ; CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/immunology

  • Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Nov 17; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 17.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.

  • Authors : Decroos A; Université de Poitiers, Institut National de la Santé Et de la Recherche Médicale, Ischemie Reperfusion Métabolisme et Inflammation Stérile en Transplantation U1313, Poitiers, France.; Centre Hospitalier Universitaire de Poitiers, Délégation à la Recherche Clinique et à l'Innovation, Poitiers, France.

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/immunology ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 15; Vol. 15, pp. 1473139. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Single-cell RNA sequencing reveals anti-tumor potency of CD56 + NK cells and CD8 + T cells in humanized mice via PD-1 and TIGIT co-targeting.

  • Authors : Liu WN; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.; Harden SL

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/metabolism ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/antagonists & inhibitors

  • Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Nov 06; Vol. 32 (11), pp. 3895-3914. Date of Electronic Publication: 2024 Sep 23.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Precision Engineered Interleukin-2 for Bolstering CD8+ T- and NK-cell Activity without Eosinophilia and Vascular Leak Syndrome in Nonhuman Primates.

  • Authors : Ma L; Synthorx, Inc., A Sanofi Company, La Jolla, California.; Acuff NV

Subjects: CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/immunology ; CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/drug effects ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology

  • Source: Cancer research communications [Cancer Res Commun] 2024 Oct 01; Vol. 4 (10), pp. 2799-2814.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Protein phosphatase 2A inhibitor modulates natural killer cell homeostasis in peripheral tissues.

  • Authors : Shinzawa Y; Section of Host Defences, Institute of Natural Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194, Japan. Electronic address: .; Sasaki SI

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/drug effects ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/metabolism

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Dec 31; Vol. 741, pp. 151020. Date of Electronic Publication: 2024 Nov 19.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer.

  • Authors : Han E; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi, Republic of Korea.; Choi HY

Subjects: Lymphocytes, Tumor-Infiltrating*/Lymphocytes, Tumor-Infiltrating*/Lymphocytes, Tumor-Infiltrating*/immunology ; Lymphocytes, Tumor-Infiltrating*/Lymphocytes, Tumor-Infiltrating*/Lymphocytes, Tumor-Infiltrating*/metabolism ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/immunology

  • Source: Breast cancer research : BCR [Breast Cancer Res] 2024 Dec 06; Vol. 26 (1), pp. 180. Date of Electronic Publication: 2024 Dec 06.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Upregulation of NK cell activity, cytokine expression, and NF-κB pathway by ginsenoside concentrates from Panax ginseng berries in healthy mice and macrophage cell lines.

  • Authors : Jang J; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea. Electronic address: .; He Z

Subjects: Panax*/Panax*/Panax*/chemistry ; Ginsenosides*/Ginsenosides*/Ginsenosides*/pharmacology ; NF-kappa B*/NF-kappa B*/NF-kappa B*/metabolism

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Dec 05; Vol. 335, pp. 118681. Date of Electronic Publication: 2024 Aug 08.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting PDHK1 by DCA to Restore NK Cell Function in Hepatocellular Carcinoma.

  • Authors : Yang X; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Dec 03; Vol. 23 (12), pp. 1731-1742.Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium:

Record details

×
Report

A Rare Case of NK Large Granular Lymphocytic Proliferative Disorder.

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/pathology ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/diagnosis

  • Source: Clinical laboratory [Clin Lab] 2024 Dec 01; Vol. 70 (12).Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  149,204 results for ""Killer Cells, Natural""